Bevacizumab, 10 mg

Bevacizumab finds application across laboratory and industrial settings as a monoclonal antibody, specifically a humanized IgG1 isotype. Its molecular formula is C16H21NO3, with a molecular weight of 275.34. This compound is structurally characterized by its immunoglobulin structure, which plays a role in binding to vascular endothelial growth factor (VEGF), thereby inhibiting angiogenesis. A Warning signal word indicates potential hazards when handling this substance, primarily due to its acute toxicity when ingested. Bevacizumab is used extensively in therapeutic applications, particularly in the treatment of various cancers.

• CAS Number: 216974-75-3
• Molecular Weight: 275.34
• GHS Signal Word: Warning
• Exact Mass: 275.15214353
• Molecular Formula: C16H21NO3
• Hazard Statements:
• H302: Harmful if swallowed [Warning Acute toxicity, oral]